The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| OVIT | -50% | -99.71% | -68.9% | -100% |
| S&P | +14.43% | +77.25% | +12.13% | +372% |
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate. The company was founded on January 8, 1999 and is headquartered in San Antonio, TX.
No news articles found for OncoVista Innovative Therapies.
No data available for this period.
Currently no data to display
Currently no data to display.
Currently no data to display.
No data available for this period.
No data available for this period.
No data available for this period.
No data available for this period.
| Metric | YoY Change |
|---|
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
